Four years after its Kickstarter campaign closed, Penny Blood still doesn’t have a publisher. On October 2, 2026, series creator Matsuzo Machida gave backers and fans the update nobody wanted but most expected: the Shadow Hearts spiritual successor remains without a publishing partner, and the main game’s production has not moved forward. As AUTOMATON reported, the studio behind the project “still hasn’t secured a publisher, but has not given up on the project.”
The update lands at a particularly rough moment for the project’s extended family. Weeks earlier, Armed Fantasia, the Wild Arms-inspired game that launched alongside Penny Blood in the same 2022 “Double Kickstarter,” was quietly killed off by its publisher. That leaves Penny Blood as the sole survivor of a crowdfunding campaign that once looked like a model for reviving beloved JRPG franchises outside the big publishers. Four years, one lawsuit, two spinoff novels, and a cancelled sibling game later, the main RPG still has no release date, no price, and now, no stablemate.
What Machida actually said on October 2
According to Noisy Pixel’s report on the update, Machida described the situation bluntly: “the situation surrounding the game industry has become extremely difficult in recent years, and we have still not been able to find a publisher.” It’s a line that doubles as both an apology to backers and a diagnosis of the broader market Penny Blood is trying to break into.
Machida pointed to two specific pressures. First, the cost and risk profile of large-scale RPG development has climbed sharply, making publishers more cautious about funding ambitious, narrative-heavy JRPGs from independent studios. Second, publishers are increasingly gravitating toward established intellectual property rather than new, crowdfunded ones, even when that IP carries the pedigree of a beloved creator. Penny Blood checks the “respected creator” box, since Machida wrote the scenarios for the original Shadow Hearts series on PS2, but it doesn’t check the “known franchise” box in the eyes of risk-averse publishing executives.
Crucially, Machida did not announce cancellation. Studio Wildrose, the developer Machida founded after leaving the Shadow Hearts series’ original publisher, is still actively working on Penny Blood-adjacent content, and the studio describes itself as committed to finishing the main game once a publishing deal is in place. The update is a status report, not an obituary, but after four years of stalled progress, the distinction is getting harder for fans to hold onto.
From Shadow Hearts to Penny Blood: the pitch
Shadow Hearts was a cult JRPG series on the original PlayStation and PlayStation 2, known for its dark, horror-tinged tone, a historical early-20th-century setting, and the Judgment Ring battle mechanic that layered timing-based inputs onto standard turn-based combat. Machida wrote the scenarios for the series. When the Shadow Hearts IP wasn’t available to revive directly, Machida and artist Miyako Kato set out to build a spiritual successor under a new name, carrying over the tone, the era, and much of the creative DNA without the trademark baggage.
Penny Blood is set in the 1920s, framed as a Roaring Twenties period piece with cosmic-horror elements running underneath the historical setting, and it uses a combat system built around a mechanic the team calls the Psycho Sigil, a clear conceptual heir to the Judgment Ring. For backers who grew up on Shadow Hearts: From the New World and the series’ blend of pulp horror and black comedy, Penny Blood was pitched as the closest thing possible to getting the band back together without owning the original name.
The 2022 Double Kickstarter and its unraveling
Penny Blood wasn’t funded alone. In 2022, it launched a joint “Double Kickstarter” campaign alongside Armed Fantasia, a separate spiritual successor to Wild Arms developed by a different team under scenario director Mado Sekiya. Bundling the two campaigns let publisher Dangen Entertainment pitch backers on reviving two beloved late-90s/2000s JRPG franchises at once. According to PC Gamer, the combined campaign raised nearly $3 million, a substantial haul that should have given both projects real production runway.
It didn’t work out that way for Penny Blood. By autumn 2023, the Kickstarter funds had reportedly run dry, and the project stalled. The explanation came into focus in May 2024, when Machida filed a lawsuit against Dangen Entertainment and its co-founder, Ben Judd, alleging the publisher had failed to pay out funds raised through the Kickstarter campaign. RPGFan’s coverage of the suit noted that because Studio Wildrose wasn’t receiving the money it was owed, development slowed to a crawl, and the team began quietly searching for a new publisher around the same time news of the lawsuit broke.
That lawsuit effectively reset Penny Blood’s publishing situation back to zero. Dangen Entertainment, which managed the original Kickstarter and held the publishing rights, was no longer a functioning partner, but Studio Wildrose had to find an entirely new publisher willing to pick up a project that was already mired in legal and financial disputes, a much harder sell than publishing an original pitch.
Penny Blood development timeline
| Date | Event | Source |
|---|---|---|
| 2022 | Joint “Double Kickstarter” launches for Penny Blood and Armed Fantasia, publisher Dangen Entertainment; campaign raises nearly $3 million combined | PC Gamer |
| Autumn 2023 | Kickstarter funds for Penny Blood reportedly exhausted; main game production stalls | Perplexity/AUTOMATON research |
| May 2024 | Machida files lawsuit against Dangen Entertainment and co-founder Ben Judd over unpaid Kickstarter funds | RPGFan |
| December 2024 | Spinoff roguelike action game Penny Blood: Hellbound releases on Steam, drawing modest attention | The Gamer |
| Late 2024 | “Inheritor’s Story” novel volumes (Hide Seeker, The Vessel of Spirit Summoning, Erebus) published to build IP awareness | AUTOMATON |
| March 2026 | Machida gives update confirming talks are underway to resume content production; publisher still not found | Noisy Pixel |
| March 2026 | Prequel novel Penny Blood: REVIOLENCE announced, following protagonist Matthew, a WWI veteran; Fall 2026 release window set | Noisy Pixel |
| September 2026 | Sibling project Armed Fantasia discontinued by publisher 505 Games/Digital Bros | Gematsu, PC Gamer |
| October 2, 2026 | Machida confirms Penny Blood still has no publisher; main game production has not progressed | AUTOMATON, Game*Spark |
The Armed Fantasia problem: a sibling project just died
The timing of Machida’s October update is hard to separate from what happened to Armed Fantasia a few weeks earlier. According to PC Gamer’s reporting, 505 Games’ parent company Digital Bros disclosed in a September 2026 earnings report that it had discontinued development of Armed Fantasia, alongside two other projects, as part of a non-cash asset impairment of €18.7 million. Of that figure, roughly €17.6 million was tied to write-offs on the discontinued titles, with the remainder reflecting lower sales expectations on other games already in the Digital Bros portfolio.
Armed Fantasia had, until that point, been the more visibly active half of the 2022 Double Kickstarter. It had shown off work-in-progress battle footage as recently as this year, and had a confirmed, known publisher behind it the whole way through. Its cancellation is a reminder that having a publisher attached is no guarantee of release either. A publisher can fund a game for years and still walk away once the math stops working, and for a mid-sized publisher like 505 Games, facing broader impairment pressure across its slate, an ambitious crowdfunded RPG revival was evidently an easier line item to cut than to finish.
For Penny Blood, that outcome cuts both ways. On one hand, it validates Machida’s stated caution: publishers really are pulling back from exactly this kind of project right now, and Armed Fantasia’s fate is Exhibit A. On the other hand, it removes Penny Blood’s sole point of comparison, the other half of the campaign that backers could point to and say, “well, at least that one’s still moving.” Now Penny Blood stands alone as the only unfinished product of that 2022 funding round, carrying the full weight of nearly $3 million in backer expectations with nothing shipped to show for the core game.
Penny Blood vs. Armed Fantasia: where each project stands
| Metric | Penny Blood | Armed Fantasia |
|---|---|---|
| Spiritual successor to | Shadow Hearts | Wild Arms |
| Studio/director | Studio Wildrose / Matsuzo Machida | Separate studio / Mado Sekiya |
| Original publisher | Dangen Entertainment | 505 Games (Digital Bros) |
| Current publisher status | None; actively searching | N/A — project discontinued |
| Legal disputes | Machida sued Dangen Entertainment, May 2024 | None reported |
| Spinoff content shipped | Penny Blood: Hellbound (Steam, Dec. 2024); two novel series | None reported |
| Most recent public status update | October 2, 2026, no publisher | September 2026, discontinued |
| Platforms targeted | PS5, Xbox Series X|S, PC | PS5, Xbox Series X|S, PC (as announced) |
Building IP value without a game to sell
Unable to fund the main RPG, Studio Wildrose has spent the last two years pursuing an unusual strategy: expanding the Penny Blood universe through cheaper, lower-risk side projects instead. The clearest example is the “Inheritor’s Story” novel series, published across multiple volumes in late 2024, including titles translated as Hide Seeker, The Vessel of Spirit Summoning, and Erebus. According to AUTOMATON’s earlier coverage, the paperback print editions of these books have reportedly outsold their digital counterparts, an unusual pattern for tie-in fiction that suggests a dedicated, if modest, print-collecting fanbase around the IP.
Building on that, the studio announced a new prequel novel, Penny Blood: REVIOLENCE, in March 2026, with a Fall 2026 release window. Per Noisy Pixel’s reporting, the story follows a protagonist named Matthew, a World War I veteran, set before the events of the planned main game. The explicit goal, in Machida’s own framing, is to raise the IP’s visibility and value to the point where a publisher sees Penny Blood as a known quantity worth betting on, rather than an unproven pitch from a studio still tangled in legal fallout from its last deal.
It’s a workaround, not a solution. Novels and spinoff games can keep a fanbase engaged and demonstrate creative output, but they don’t substitute for the capital a full RPG production actually requires. The strategy buys time and goodwill; it doesn’t buy a development budget.
Hellbound: the spinoff that didn’t move the needle
Before the novels, Studio Wildrose tried a more direct approach: shipping an actual game. Penny Blood: Hellbound, a roguelike action spinoff set in the same universe, launched on Steam in December 2024. The idea was straightforward: give backers something playable now, generate revenue, and prove there’s commercial demand for the IP. According to The Gamer’s reporting, the results were underwhelming. Hellbound drew only around 68 reviews on Steam, a figure that signals a niche release rather than a breakout proof-of-concept.
That modest reception matters for the publisher search. A spinoff that quietly underperforms doesn’t give a prospective publisher the kind of commercial validation that would offset the risk of the studio’s unresolved legal history. If anything, Hellbound’s numbers reinforce the exact caution Machida described: without an established franchise behind it, even a functional, shipped Penny Blood product struggles to cut through.
Why publishers are retreating from mid-budget RPGs
Penny Blood’s struggle is specific, but the pattern isn’t. Mid-budget, narrative-driven RPGs sit in an uncomfortable spot in today’s publishing landscape: too expensive and labor-intensive to be a low-risk indie bet, but without the guaranteed install base of an established franchise or live-service hook that justifies AAA-scale marketing spend. Digital Bros’ decision to write off Armed Fantasia as part of a broader €18.7 million impairment shows that even publishers with a game already deep in development will cut their losses once the cost-to-reward math shifts.
That dynamic is squeezing the exact category of game Penny Blood represents: a passion project built on nostalgia for a specific, beloved but commercially modest franchise, led by the original creative talent, funded initially by crowdfunding rather than a publisher’s upfront investment. It’s a model that worked well enough in the mid-2010s to fund several notable revivals. In 2026’s publishing environment, with development costs climbing and publishers consolidating around fewer, bigger bets, that same model is proving much harder to carry across the finish line.
Historical context: when crowdfunded revivals do work
Penny Blood isn’t the first spiritual successor to a cult JRPG franchise to rely on crowdfunding, and its struggles stand out partly because other, similar projects did eventually reach players. Bloodstained: Ritual of the Night, a spiritual successor to Castlevania led by series veteran Koji Igarashi, also began life as a Kickstarter campaign before eventually finding a publishing partner and shipping years after its initial funding. That project’s path, crowdfund first, secure a publisher during development, then ship, is roughly the model Penny Blood’s team has been chasing since 2022. The difference is that Penny Blood lost its publisher mid-stream rather than never having to search for one after the fact.
That history matters for how backers should read Machida’s October update. A stalled publisher search four years in isn’t automatically a death sentence for a crowdfunded RPG; some of the genre’s best-loved revivals took a similarly circuitous route to release. But it does mean the project’s runway is being measured in years, not months, and every additional delay raises the bar for what the eventual game will need to deliver to justify the wait.
Market impact: what this means for crowdfunded game publishing
For the wider crowdfunded games space, the Penny Blood and Armed Fantasia situations together form a cautionary case study. Backers who fund a Kickstarter campaign are typically pledging toward a creative vision and a studio’s reputation, not a publisher’s balance sheet, yet it’s the publisher relationship that ultimately determines whether a funded game reaches release. When that relationship breaks down, as it did between Studio Wildrose and Dangen Entertainment, or gets abandoned outright, as 505 Games did with Armed Fantasia, backers have little recourse beyond watching for updates and hoping the studio can regroup.
It also raises the stakes for how future crowdfunding campaigns in this space get structured. A joint campaign spreading risk, and marketing reach, across two games made sense in 2022 as a way to maximize backer interest in spiritual successors to beloved JRPG franchises. Four years later, that bundling hasn’t protected either project: one has been formally discontinued, and the other remains in limbo. Studios weighing similar crowdfunded revivals going forward will likely need to secure firmer publisher commitments, with contractual fund-release protections, before launching a campaign rather than after.
What’s next for Studio Wildrose
In the near term, Studio Wildrose’s public-facing roadmap consists almost entirely of the REVIOLENCE novel, due in Fall 2026, rather than any new information about the main RPG. Machida’s statements continue to frame the publisher search as active and ongoing rather than abandoned, and the studio has repeatedly emphasized it has not given up on finishing the game that originally drew nearly $3 million in backer support. But four years without a confirmed deal, a now-discontinued sibling project, and a modestly received spinoff all weigh against the studio’s leverage in publisher negotiations.
Penny Blood’s confirmed target platforms, PS5, Xbox Series X|S, and PC, remain unchanged, but with no release date or price set, those platform commitments are aspirational rather than locked in. Everything about the game’s actual production timeline depends on a single unresolved variable: finding a publisher willing to fund a mid-budget, horror-tinged JRPG from a studio that just watched its crowdfunding sibling get cancelled.
Predictions: where Penny Blood goes from here
- Expect Studio Wildrose to lean further into tie-in fiction and spinoff content through 2027 as a low-cost way to keep the Penny Blood brand visible while the publisher search continues.
- Penny Blood: REVIOLENCE’s Fall 2026 reception will likely shape how Machida frames the next public update; stronger-than-expected sales could be cited as evidence of IP momentum in publisher pitches.
- Armed Fantasia’s cancellation will probably be referenced by other crowdfunded-RPG studios as a cautionary example when structuring future publisher agreements and fund-release terms.
- A publisher announcement, if one comes, is more likely from a mid-sized or indie-focused label willing to take on a smaller bet than from a major publisher already retreating from mid-budget RPGs.
- Absent a publisher deal within the next year or two, pressure will grow on Studio Wildrose to explore an alternative funding path, such as a platform-holder partnership or a scaled-down version of the original pitch.
Frequently asked questions
Has Penny Blood been cancelled?
No. As of the October 2, 2026 update, Studio Wildrose says it has not given up on the project, even though it still has not secured a publisher and main game production has not progressed, according to AUTOMATON’s reporting.
Who is Matsuzo Machida?
Machida is the scenario writer behind the original Shadow Hearts series and the director of Studio Wildrose, the studio developing Penny Blood as a spiritual successor to that franchise.
What platforms is Penny Blood planned for?
Penny Blood has been announced for PlayStation 5, Xbox Series X|S, and PC. No release date or price has been set.
Why doesn’t Penny Blood have a publisher?
According to Machida, rising costs and risk in large-scale RPG development, combined with publishers favoring established intellectual property over new properties, have made it difficult to secure a deal. The studio’s unresolved 2024 lawsuit against original publisher Dangen Entertainment over unpaid Kickstarter funds has also complicated the search.
What happened to Armed Fantasia?
Armed Fantasia, the Wild Arms spiritual successor that launched alongside Penny Blood in the same 2022 joint Kickstarter, was discontinued in September 2026 by publisher 505 Games. Parent company Digital Bros disclosed the decision as part of an earnings report citing non-cash impairment losses of €18.7 million.
Is Penny Blood: Hellbound the same as the main game?
No. Penny Blood: Hellbound is a separate roguelike action spinoff set in the Penny Blood universe, released on Steam in December 2024. It is not the mainline RPG that was originally crowdfunded in 2022.
What was the lawsuit against Dangen Entertainment about?
In May 2024, Machida filed a lawsuit against Dangen Entertainment and co-founder Ben Judd, alleging the publisher failed to pay out funds raised through the 2022 Kickstarter campaign, which reportedly slowed development and prompted the search for a new publisher.
When is the Penny Blood: REVIOLENCE novel coming out?
Penny Blood: REVIOLENCE, a prequel novel following a WWI veteran named Matthew, was announced in March 2026 with a release window of Fall 2026.
Related
- PlatinumGames Has 0 Switch 2 Games, Teases Bayonetta [2026]
- Persona 4 Revival Shadow Trailer Confirms Feb. 2027 [2026]
- Jagex’s RS4: RuneScape’s 4th MMO, Unreal Engine [2026]
- Steam Quietly Rewrites Algorithm for 135K Games [2026]
- 7 Massive Games Left in 2026 as Rivals Dodge GTA 6 [2026]